Hosted on MSN
Atomic-level mapping of amorphous diabetes drug reveals hydrogen bonds as key to stability
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated on a GLP-1 receptor agonist candidate for diabetes and obesity treatment.
Achieved the first spectroscopic observation of hydrogen (H 2) and deuterium (D 2) molecules physically adsorbed within an atomic-scale space known as a picocavity. Employed picometric ...
Researchers have observed hydrogen and deuterium molecules in tiny spaces called picocavities using advanced spectroscopy. This study reveals unique differences between the molecules due to quantum ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results